5
Views
0
CrossRef citations to date
0
Altmetric
Articles

Evaluation of TERT mRNA alternative spliced variants in aortic endothelial cells of the rabbit, in the fatty streaks stage of atherosclerosis

, , &
Pages 7-12 | Received 24 Apr 2006, Accepted 06 Oct 2006, Published online: 23 May 2017

References

  • Brunori M, Gilson E. The opposite roles of telomerase dur-ing initiation and progression of cancers. J Soc Biol 2004; 198(2): 105–11.
  • Derradji H, Bekaert S, Van Oostveldt P, Baatout S. Com-parison of different protocols for telomere length estima-tion by combination of quantitative fluorescence in situ hybridization (Q-FISH) and flow cytometry in human can-cer cell lines. Anticancer Res 2005; 25(2A): 1039-50.
  • Polychronopoulou S, Koutroumba P. Telomere length and telomerase activity: variations with advancing age and poten-tial role in childhood malignancies. J Pediatr Hematol Oncol 2004; 26(6): 342–50.
  • Flanary BE, Kletetschka G. Analysis of telomere length and telomerase activity in tree species of various life-spans, and with age in the bristlecone pine Pinus longaeva. Biogeron-tology 2005; 6(2): 101–11.
  • Chan SR, Blackburn EH. Telomeres and telomerase. Philos Trans R Soc Lond B Biol Sci 2004; 359(1441): 109–21.
  • Bates SE, Zhou NY, Federico LE, Xia L, O’Connor TR. Repair of cyclobutane pyrimidine dimers or dimethylsulfate damage in DNA is identical in normal or telomerase-immor-tali7ed human skin fibroblasts. Nucleic Acids Res 2005; 33(8): 2475–85.
  • Baykal A, Rosen D, Zhou C, Liu J, Sahin AA. Telomerase in breast cancer: a critical evaluation. Adv Anat Pathol 2004; 11(5): 262–8.
  • Kelland LR. Overcoming the immortality of tumor cells by telomere and telomerase based cancer therapeutics-current status and future prospects. Eur J Cancer 2005; 41(7): 971–9.
  • Rama S, Suresh Y, Rao AJ. Regulation of telomerase dur-ing human placental differentiation: a role for TGFbeta 1 . Mol Cell Endocrinol 2001; 182(2): 233–48.
  • Liu WJ, Zhang YW, Zhang ZX, Ding J. Alternative splicing of human telomerase reverse transcriptase may not be involved in telomerase regulation during all-trans-retinoic acid-induced HL-60 cell differentiation. J Pharmacol Sci 2004; 96(2): 106–14.
  • Kimura A, Ohmichi M, Kawagoe J, Kyo S, Mabuchi S, Takahashi T, Ohshima C, Arimoto-Ishida E, Nishio Y, Inoue M, Kurachi H, Tasaka K, Murata Y Induction of hTERT expression and phosphorylation by estrogen via Akt cascade in human ovarian cancer cell lines. Onco gene 2004; 23(26): 4505–15.
  • Khurts S, Masutomi K, Delgermaa L, Arai K, Oishi N, Mizuno H, Hayashi N Hahn WC, Murakami S. Nucleolin interacts with telomerase. J Biol Chem 2004; 279(49): 51508–15.
  • Forsythe HL, Jarvis JL, Turner JW, Elmore LW, Holt SE. Stable association of hsp90 and p23, but Not hsp70, with active human telomerase. J Biol Chem 2001; 276(19): 15571–4.
  • Kelleher C, Kurth I, Lingner J. Human protection of telom-eres 1 (POT1) is a negative regulator of telomerase activity in vitro. Mol Cell Biol 2005; 25(2): 808–18.
  • Hisatomi H, Ohyashiki K, Ohyashiki JH, Nagao K, Kana-maru T, Hirata H, Hibi N, Tsukada Y. Expression profile of a gamma-deletion variant of the human telomerase reverse transcriptase gene. Neoplasia 2003; 5(3): 193–7.
  • Yi X, White DM, Aisner DL, Baur JA, Wright WE, Shay JW. An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity. Neoplasia 2000; 2(5): 433–40.
  • Kurz DJ, Decary S, Hong Y, Trivier E, Akhmedov A, Erusal-imsky JD. Chronic oxidative stress compromises telomere integrity and accelerates the onset of senescence in human endothelial cells. J Cell Sci 2004; 117(Pt 11): 2417–26.
  • Minamino T, Miyauchi H, Yoshida T, Ishida Y, Yoshida H, Komuro I. Endothelial cell senescence in human athero-sclerosis: role of telomere in endothelial dysfunction. Circu-lation 2002; 105(13): 1541–4.
  • Zaccagnini G, Gaetano C, Della Pietra L, Nanni S, Grasselli A, Mangoni A, Benvenuto R, Fabrizi M, Truffa S, Germani A, Moretti F, Pontecorvi A, Sacchi A, Bacchetti S, Capogrossi MC, Farsetti A. Telomerase mediates vascular endothelial growth factor-dependent responsiveness in a rat model of hind limb ischemia. J Biol Chem 2005; 280(15): 14790–8.
  • Matsushita H, Chang E, Glassford AJ, Cooke JP, Chiu CP, Tsao PS. eNOS activity is reduced in senescent human endothelial cells: Preservation by hTERT immortalization. Circ Res 2001; 89(9): 793–8.
  • Imanishi T, Hano T, Sawamura T, Nishio I. Oxidized low-density lipoprotein induces endothelial progenitor cell senes-cence, leading to cellular dysfunction. ClM Exp Pharmacol Physiol 2004; 31(7): 407–13.
  • Breitschopf K, Zeiher AM, Dimmeler S. Pro-atherogenic factors induce telomerase inactivation in endothelial cells through an Akt-dependent mechanism. FEBS Lett 2001; 493(1): 21–5.
  • Haendeler J, Hoffmann J, Diehl JF, Vasa M, Spyridopoulos I, Zeiher AM, Dimmeler S. Antioxidants inhibit nuclear export of telomerase reverse transcriptase and delay replica-tive senescence of endothelial cells. Circ Res 2004; 94(6): 768–75.
  • Ulaner GA, Hu JF, Vu TH, Giudice LC, Hoffman AR. Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcrip-tion and by alternate splicing of hTERT transcripts. Cancer Res 1998; 58(18): 4168–72.
  • Minamino T, Komuro I. Role of telomere in endothelial dys-function in atherosclerosis. Curr Opin Lipidol 2002; 13(5): 537–43.
  • Gisselsson D, Lv M, Tsao SW, Man C, Jin C, Hoglund M, Kwong YL, Jin Y Telomere-mediated mitotic disturbances in immortalized ovarian epithelial cells reproduce chromosomal losses and breakpoints from ovarian carcinoma. Genes Chromosomes Cancer 2005; 42(1): 22–33.
  • Ducray C, Pommier JP, Martins L, Boussin FD, Sabatier L.Telomere dynamics, end-to-end fusions and telomerase activation during the human fibroblast immortalization process. Oncogene 1999; 18(29): 4211–23.
  • Stindl R. Tying it all together: telomeres, sexual size dimor-phism and the gender gap in life expectancy. Med Hypothe-ses 2004; 62(1): 151–4.
  • Baird DM. New developments in telomere length analysis. Exp Gerontol 2005; 40(5): 363–8.
  • Meeker AK, De Marzo AM. Recent advances in telomere biology: implications for human cancer. Curr Opin Oncol 2004; 16(1): 32–8.
  • Minamino T, Kourembanas S. Mechanisms of telomerase induction during vascular smooth muscle cell proliferation. Circ Res 2001; 89(3): 237–43.
  • Lucas AD, Greaves DR. Atherosclerosis: role of chemokines and macrophages. Expert Rev Mol Med 2001; 2001: 1–18.
  • Minamino T, Komuro I. The role of telomerase activation in the regulation of vascular smooth muscle cell prolifera-tion. Drug News Perspect 2003; 16(4): 211–6.
  • Fleiner M, Kummer M, Mirlacher M, Sauter G, Cathomas G, Krapf R, Biedermann BC. Arterial neovascularization and inflammation in vulnerable patients: early and late signs of symptomatic atherosclerosis. Circulation 2004; 110(18): 2843–50.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.